K
62
2
LB
37
-7
HES
40
-3
ADP
79
2
GE
77
3
DD
33
-4
DUK
59
5
ALL
63
2
DGX
46
3
MU
55
-4
BEN
36
-2
VTR
44
3
M
28
-3
HON
67
4
SYF
60
-2
CMI
55
-3
PSA
55
2
RHI
28
-2
VRSN
50
-8
DTE
56
2
K
62
2
LB
37
-7
HES
40
-3
ADP
79
2
GE
77
3
DD
33
-4
DUK
59
5
ALL
63
2
DGX
46
3
MU
55
-4
BEN
36
-2
VTR
44
3
M
28
-3
HON
67
4
SYF
60
-2
CMI
55
-3
PSA
55
2
RHI
28
-2
VRSN
50
-8
DTE
56
2
Financhill
Back

Alaunos Therapeutics 10K Form

Sell
35

TCRT
Alaunos Therapeutics

Last Price:
$2.45
Seasonality Move:
0.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-772K
Price / Cash Flow: 0
Annual Sales: $0.66
Price / Book: 3.81

Profitability

EPS (TTM): -2.54000
Net Income (TTM): $-4.1M
Gross Margin: $0
Return on Equity: -141.23%
Return on Assets: -106.35%

Alaunos Therapeutics Earnings Forecast

Key Alaunos Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for TCRT have been equal to 44,600.00% of Gross Profit Margin.
  • The Research & Development expenses have been 3,620.00% of Revenue.
  • The Net Earning history of TCRT is -46,790.00% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Alaunos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1
Quick Ratio: 0.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Sell
35
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy or a Sell?